The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
2021
DOI: 10.1016/j.asmr.2020.11.002
|View full text |Cite
|
Sign up to set email alerts
|

Improved Short-Term Outcomes of Osteochondral Lesions of the Knee Following Arthroscopic Treatment With Bone Marrow Aspirate Concentrate and Cartilage-Derived Matrix

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 32 publications
0
1
0
Order By: Relevance
“…One recently proposed biologic therapy includes the use of BMAC with a dehydrated, micronized allogeneic cartilage-derived matrix scaffold (CDM) for grade 4 FCDs. 14 , 15 The purpose of this study was to compare the outcomes of patients undergoing treatment of FCDs of the knee joint with chondroplasty versus BMAC and CDM implantation. The authors hypothesized that the BMAC/CDM group would demonstrate better postsurgical outcomes than the chondroplasty group.…”
mentioning
confidence: 99%
“…One recently proposed biologic therapy includes the use of BMAC with a dehydrated, micronized allogeneic cartilage-derived matrix scaffold (CDM) for grade 4 FCDs. 14 , 15 The purpose of this study was to compare the outcomes of patients undergoing treatment of FCDs of the knee joint with chondroplasty versus BMAC and CDM implantation. The authors hypothesized that the BMAC/CDM group would demonstrate better postsurgical outcomes than the chondroplasty group.…”
mentioning
confidence: 99%